Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate Pre-treatment for Deep Neuromuscular Blockade With Rocuronium
NCT02989272Phase 4Unknown
- Sponsor
- Hospital Federal de Bonsucesso
- Start
- Dec 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of magnesium sulfate in neuromuscular blockade (NMB), sponsored by Hospital Federal de Bonsucesso. Primary endpoint: Duration of deep neuromuscular block. Status: unknown.
02
Drugs
magnesium sulfate
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02989272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02989272.